Business Expansion & Acquisitions - Pharma Industry in India

Partner with Us

Working together
towards a healthier
world.

Mankind has a history of partnering with organizations that leverage their expertise in development of complex multisource products, complementing our in-house development programs. Mankind brings robust Product Selection, Technical, IP, Regulatory, and Financial expertise, and a commitment to mutually beneficial relationships.

Partnership is an integral part of our business strategy and we are keen to collaborate with partners who support us in our mission of enriching lives of patients by offering them high-quality and affordable therapeutic options.

About
Mankind

Mankind Pharma is the 4th largest pharma company in India by sales revenue and ranks No. 1 in prescription volume. With the largest sales force in the country, it covers over 70% of prescribing doctors across metros, non-metros, and Tier 1/2/3 cities. The company has a strong presence in 20+ therapy areas, excelling in both acute and chronic treatments, and has rapidly built several mega brands. Some of our major therapy areas include:

anti-infectives

15%

Anti-infectives portfolio share in domestic sales

cardiovascular

15%

Cardiovascular portfolio share in domestic sales

Anti-Diabetic

Anti-diabetic portfolio share in domestic sales

Respiratory

Respiratory portfolio share in domestic sales

Gynaecology

Gynaecology portfolio share in our domestic sales

Gastrointestinal

10%

Gastrointestinal portfolio share in domestic sales

Neuro / CNS

Neuro/CNS portfolio share in domestic sales

Dermatology

Dermatology portfolio share in domestic sales

Pain / Analgesics

Pain / Analgesics portfolio share in domestic sales

Vitamins / Minerals / Nutrients

VMN portfolio share in domestic sales

Apart from the Sales & Marketing capabilities, Mankind has proven competencies in Regulatory, Clinical Research, Formulation R&D and Manufacturing which have helped commercialise the partnered products in a reasonable time frame. Our capabilities in the above mentioned areas have made us the partner of choice for many MNCs and major Pharma companies in multiple geographies.

Our Partners

Brand/Molecule

Neptaz

Co-marketing arrangement for VALSARTAN/SACUBITRIL Novel Heart failure treatment

Partner

Brand/Molecule

Symbicort

Co-marketing arrangement for VALSARTAN/SACUBITRIL Novel Heart failure treatment

Partner

Brand/Molecule

Crenzlo

Co-marketing arrangement for INCLISIRAN - Novel treatment of high low-density lipoprotein cholesterol

Partner

Brand/Molecule

Nobeglar

Co-marketing of Insulin Glargine

Partner

Brand/Molecule

Insulin Aspart

Exclusive partnership for Insulin Aspart analogue

Partner

Brand/Molecule

Vono

Non-Exclusive Patent License Agreement to launch the novel drug for treating GERD under its trademark.

Partner

Partners in 
Emerging Markets

Mankind is actively seeking in-licensing opportunities for product dossiers or MA acquisitions to ensure faster turnarounds and easy access. We are focused on larger acquisitions in EM target markets and have already in-licensed products from major European suppliers. Now, we aim to expand partnerships with other EU and EM suppliers.

We welcome collaborations with partners developing or having developed novel, unique, or differentiated drugs, biologics (Phase 2/3 to commercialized), and medical devices that can enhance our portfolio in the mentioned therapy areas.